Medical Research Council (United Kingdom)
The Medical Research Council is responsible for co-coordinating and funding medical research in the United Kingdom. It is part of United Kingdom Research and Innovation, which came into operation 1 April 2018, and brings together the UK's seven research councils, Innovate UK and Research England. UK Research and Innovation is answerable to, although politically independent from, the Department for Business, Energy and Industrial Strategy.
The MRC focuses on high-impact research and has provided the financial support and scientific expertise behind a number of medical breakthroughs, including the development of penicillin and the discovery of the structure of DNA. Research funded by the MRC has produced 32 Nobel Prize winners to date.
History
The MRC was founded as the Medical Research Committee and Advisory Council in 1913, with its prime role being the distribution of medical research funds under the terms of the National Insurance Act 1911. This was a consequence of the recommendation of the Royal Commission on Tuberculosis, which recommended the creation of a permanent medical research body. The mandate was not limited to tuberculosis, however.In 1920, it became the Medical Research Council under Royal Charter. A supplementary Charter was formally approved by the Queen on 17 July 2003. In March 1933, MRC established the first scientific published medical patrol named British Journal of Clinical Research and Educational Advanced Medicine, as a periodical publication intended to further the progress of science, usually by reporting new research. It contain articles that have been peer reviewed, in an attempt to ensure that articles meet the journal's standards of quality, and scientific validity, allow researchers to keep up to date with the developments of their field and direct their own research.
In August 2012, the creation of the MRC-NIHR Phenome Centre, a research centre for personalised medicine, was announced. The MRC-NIHR National Phenome Centre is based at Imperial College London and is a combination of inherited equipment from the anti-doping facilities used to test samples during the 2012 Olympic and Paralympic Games. and additional items from the Centre's technology partners Bruker and Waters Corporation. The Centre, led by Imperial College London and King's College London, is funded with two five-year grants of £5 million from the Medical Research Council and the National Institute for Health Research and was officially opened in June 2013.
Notable research
Important work carried out under MRC auspices has included:- the identification of the dietary cause of rickets by Sir Edward Mellanby. Mellanby also carried out human experimentation regarding vitamin A and C deficiencies on volunteers at the Sorby Research Institute;
- the discovery, in 1918, that influenza is caused by a virus;
- the description of neurotransmission and the first neurotransmitter, acetylcholine, by Sir Henry Hallett Dale and Otto Loewi, leading to a Nobel Prize for Physiology or Medicine in 1936;
- the development of penicillin by Sir Alexander Fleming, Sir Ernst Boris Chain and Lord Florey, gaining them the 1945 Nobel Prize;
- linkage of lung cancer to tobacco smoking by Sir Richard Doll and Sir Austin Bradford Hill in the British doctors study, published in 1956;
- the discovery of the structure of DNA by James D. Watson, Francis Crick, Rosalind Franklin and Professor Maurice Wilkins. Three would receive the 1962 Nobel Prize for Physiology and Medicine for their discovery;
- the development of magnetic resonance imaging in 1973 by Professor Peter Mansfield and independently by Paul Lauterbur. This would lead to the 2003 Nobel Prize;
- the development of monoclonal antibodies by César Milstein and Georges Köhler in 1975 ;
- the identification, in 1983, of folic acid as a preventive measure for spina bifida and neural tube defects;
- the conducting of large studies in the 1970s and 1980s which established that aspirin can decrease the risk of cardiovascular disease;
- the publication of the genome of C. elegans, the first multicellular organism to receive this treatment, in 1998;
- the ongoing Heart Protection Study, showing benefits of primary prevention with simvastatin in patients at high risk for cardiovascular disease;
- Dr Venki Ramakrishnan of the MRC Laboratory of Molecular Biology winning the Nobel Prize for Chemistry in 2009 for showing how ribosomes, the tiny protein-making factories inside cells, function at the atomic level;
- the discovery that early treatment of HIV-infected babies with anti-retroviral therapy can dramatically increase their chances of survival;
- the development of a test for detecting infectious prions on surgical instruments which is more accurate than previous tests and 100 times faster;
- the identification of the second ever genetic variant associated with obesity; and
- the finding that high quality surgery combined with a short course of radiotherapy can halve the rate of recurrence of colorectal cancer.
Organisation and leadership
The MRC is one of seven Research Councils which are part of UK Research and Innovation, in turn part of the Department for Business, Energy and Industrial Strategy. In the past, the MRC has been answerable to the Office of Science and Innovation, part of the Department of Trade and Industry.The MRC is advised by a council which directs and oversees corporate policy and science strategy, ensures that the MRC is effectively managed, and makes policy and spending decisions. Council members are drawn from industry, academia, government and the NHS. Members are appointed by the Secretary of State for Business, Energy and Industrial Strategy. Daily management is in the hands of the Executive Chair. Members of the council also chair specialist boards on specific areas of research. For specific subjects, the council convenes committees.
Chief Executive Officers
As Chief Executive Officers served:- 1914–33: Sir Walter Morley Fletcher
- 1933–49: Sir Edward Mellanby
- 1949–68: Sir Harold Himsworth
- 1968–77: Sir John Gray
- 1977–87: Sir James L. Gowans
- 1987–96: Sir Dai Rees
- 1996–2003: Professor Sir George Radda
- 2003–2007: Professor Sir Colin Blakemore
- 2007–2010: Professor Sir Leszek Borysiewicz
- 2010–2018: Professor Sir John Savill
- 2018–present: Professor Fiona Watt
Chairmen
- 1913–1916: The Rt Hon. Lord Moulton
- 1916–1920: Major The Hon. Waldorf Astor
- 1920–1924: The Viscount Goschen
- 1924: The Rt Hon. Edward F.L. Wood
- 1924–1929: The Rt Hon. the Earl of Balfour
- 1929–1934: The Rt Hon. Viscount D'Abernon
- 1934–1936: The Most Hon. The Marquess of Linlithgow
- 1936–1948: Lord Balfour of Burleigh
- 1948–1951: The Rt Hon. Viscount Addison
- 1952–1960: The Earl of Limerick
- 1960–1961: The Rt Hon. The Viscount Amory
- 1961–1965: The Rt Hon. Lord Shawcross
- 1965–1969: The Rt Hon. The Viscount Amory
- 1969–1978: His Grace the Duke of Northumberland
- 1978–1982: The Rt Hon. The Lord Shepherd
- 1982–1990: The Rt Hon. The Earl Jellicoe
- 1990–1998: Sir David Plastow
- 1998–2006: Sir Anthony Cleaver
- 2006–2012: Sir John Chisholm
- 2012–present: Donald Brydon, CBE
Institutes, centres and units
The following is a list of the MRC's current institutes, centres and units:
Aberdeen
- MRC Centre for Medical Mycology at the University of Aberdeen
- MRC Integrative Epidemiology Unit at the University of Bristol
- MRC Biostatistics Unit
- MRC Cancer Unit
- MRC Cognition and Brain Sciences Unit
- MRC Elsie Widdowson Laboratory
- MRC Epidemiology Unit at the University of Cambridge
- MRC Laboratory of Molecular Biology
- MRC Metabolic Diseases Unit
- MRC Mitochondrial Biology Unit
- MRC Centre for Neuropsychiatric Genetics and Genomics
- MRC Protein Phosphorylation and Ubiquitylation Unit at the University of Dundee)
- MRC Centre for Cognitive Ageing and Cognitive Epidemiology
- MRC Centre for Genetics and Molecular Medicine
- MRC Centre for Regenerative Medicine ; Stuart Forbes, Director
- MRC Centre for Reproductive Health
- MRC Human Genetics Unit at the University of Edinburgh
- The Scottish Collaboration for Public Health Research and Policy
- MRC/UVRI Uganda Research Unit on AIDS
- MRC Unit, The Gambia
- MRC/Chief Scientist Office Social and Public Health Sciences Unit, University of Glasgow
- MRC/University of Glasgow Centre for Virus Research
- MRC Mammalian Genetics Unit
- Mary Lyon Centre
- Research Complex at Harwell
- MRC Toxicology Unit
- MRC/Arthritis Research UK Centre for Integrated Research into Muscular Aging
- MRC Centre for Drug Safety Science
- MRC Asthma UK Centre in Allergic Mechanisms of Asthma
- MRC Laboratory for Molecular Cell Biology at UCL
- MRC Centre for Developmental Neurobiology
- MRC Centre for Molecular Bacteriology and Infection
- MRC Centre for Neurodegenerative Research
- MRC Centre for Neuromuscular Diseases
- MRC Centre for Global Infectious Disease Analysis
- MRC Centre for Transplantation
- MRC London Institute of Medical Sciences
- Francis Crick Institute
- MRC Clinical Trials Unit at UCL
- Centre for Environment and Health
- MRC International Nutrition Group
- MRC - National Institute for Medical Research Phenome Centre
- MRC Prion Unit
- MRC Unit for Lifelong Health and Ageing at UCL, home of the National Survey of Health & Development
- MRC Centre for Brain Ageing and Vitality
- CRUK/MRC Oxford Institute for Radiation Oncology
- MRC Brain Network Dynamics Unit at the University of Oxford
- MRC Human Immunology Unit at the University of Oxford
- MRC Molecular Haematology Unit at the University of Oxford
- MRC Population Health Research Unit at the University of Oxford
- MRC Weatherall Institute of Molecular Medicine
- Centre for Macaques
- Arthritis Research UK/MRC Centre for Musculoskeletal Health and Work
- MRC Lifecourse Epidemiology Unit at the University of Southampton
- Health Data Research UK
- UK Dementia Research Institute